David A. Siegel Berkeley Lights, Inc. Transaction History

Two Sigma Advisers, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	N/A	-278,885 Reduced 68.45%	128,568 $104,000
Q2 2023 Aug 14, 2023	SELL	$0.79 - $1.23 $39,737 - $61,869	-50,300 Reduced 10.99%	407,453 $330,000
Q1 2023 May 15, 2023	SELL	$1.04 - $2.77 $242,368 - $645,540	-233,047 Reduced 33.74%	457,753 $530,000
Q4 2022 Feb 14, 2023	SELL	$1.9 - $3.58 $151,620 - $285,684	-79,800 Reduced 10.36%	690,800 $1.85 Million
Q3 2022 Nov 14, 2022	SELL	$2.86 - $5.78 $260,832 - $527,136	-91,200 Reduced 10.58%	770,600 $2.2 Million
Q2 2022 Aug 15, 2022	SELL	$3.77 - $7.34 $896,129 - $1.74 Million	-237,700 Reduced 21.62%	861,800 $4.28 Million
Q1 2022 May 16, 2022	SELL	$5.12 - $19.26 $20,992 - $78,966	-4,100 Reduced 0.37%	1,099,500 $7.82 Million
Q4 2021 Feb 14, 2022	SELL	$17.39 - $25.74 $1.28 Million - $1.89 Million	-73,600 Reduced 6.25%	1,103,600 $20.1 Million
Q3 2021 Nov 15, 2021	BUY	$19.5 - $50.03 $19.6 Million - $50.3 Million	1,006,200 Added 588.42%	1,177,200 $23 Million
Q2 2021 Aug 16, 2021	BUY	$36.4 - $52.99 $1.33 Million - $1.93 Million	36,500 Added 27.14%	171,000 $7.66 Million
Q1 2021 May 17, 2021	BUY	$44.33 - $89.26 $5.96 Million - $12 Million	134,500 New	134,500 $6.76 Million

2.22M

Ticker BLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,283,904
Market Cap $55.3M
Description
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and applic...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.